Ceribell Inc

Rule 10b5-1 Trading Plans

On December 12, 2024, David Foehr, the Company’s Senior Vice President, Finance, adopted a 10b5-1 trading plan, which is designed to be in effect until December 15, 2025. The aggregate number of shares of common stock available to be sold pursuant to Mr. Foehr’s 10b5-1 plan is 17,223 and such shares will not be available for sale pursuant to so such plan until after April 8, 2025. Mr. Foehr’s 10b5-1 plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

On December 13, 2024, Xingjuan (Jane) Chao, Ph.D., the Company’s President and Chief Executive Officer and a member of the Company's Board of Directors, adopted a 10b5-1 trading plan, which is designed to be in effect until December 31, 2025. The aggregate number of shares of common stock available to be sold pursuant to Dr. Chao’s 10b5-1 plan is 395,000 and such shares will not be available for sale pursuant to so such plan until after April 8, 2025. Dr. Chao’s 10b5-1 plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Appointment of Chief Revenue Officer

On February 25, 2025, the Company announced that it intends to appoint Sean Manni to the position of Chief Revenue Officer. Mr. Manni, age 50, has served as the Company’s Senior Vice President, Sales, since April 2024. Prior to that, he served as the Vice President, North America Sales of Omnicell, Inc., a healthcare technology company (“Omnicell”), from 2019 to 2024. Mr. Manni also held other positions of increasing responsibility at Omnicell between 2008 and 2019. He holds a B.A. in sociology/criminal justice from East Stroudsburg University of Pennsylvania.

Departure of Chief Business Officer

Joshua Copp, the Company’s Chief Business Officer, will be departing from the Company as of March 19, 2025. Mr. Copp's departure will be subject to a separation agreement, which will include severance payments and other customary provisions. The Company expects to finalize and enter into the separation agreement with Mr. Copp in the near future, and the finalized agreement will be filed as an exhibit to the Company's next Quarterly Report on Form 10-Q.